术前腹横肌平面阻滞减少微创胆囊切除术术中阿片类药物用量
该回顾性研究纳入261例微创胆囊切除术患者,其中62例(23.8%)接受术前腹横肌平面(TAP)阻滞。结果显示术前TAP阻滞与术中阿片类药物用量(以吗啡当量剂量/手术时间计)显著降低相关(0.199 vs 0.312,p<0.001),多因素分析中TAP阻滞为独立相关因素;慢性胆囊炎则与术中阿片用量增加相关(p=0.002)。
要点
- 术前TAP阻滞与微创胆囊切除术术中阿片用量降低独立相关。
- 其他镇痛辅助药物(对乙酰氨基酚、塞来昔布等)与术中阿片用量无显著关联。
- 慢性胆囊炎病理与术中阿片用量增加相关,术前TAP阻滞应考虑常规使用。
核心结论
- 术前TAP阻滞与微创胆囊切除术术中阿片类药物用量减少相关,应考虑常规使用。
研究设计与样本
- 回顾性研究,纳入2018年6月至2021年1月期间行微创胆囊切除术的患者261例,其中62例(23.8%)接受术前TAP阻滞,199例(76.2%)未接受。
主要发现
- 术前TAP阻滞组术中阿片用量(吗啡当量剂量/手术时间)为0.199,未阻滞组为0.312,差异有统计学意义(p<0.001)。
- 术前对乙酰氨基酚(p=0.485)、塞来昔布(p=0.112)、加巴喷丁(p=0.165)及术中酮咯酸(p=0.200)与术中阿片用量无显著关联。
- 多因素分析显示术前TAP阻滞与术中阿片用量降低独立相关(p<0.001),慢性胆囊炎病理与术中阿片用量增加相关(p=0.002)。
临床怎么用
- 对微创胆囊切除术患者可考虑术前实施TAP阻滞以减少术中阿片类药物用量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ongoing epidemic of prescription opiate abuse is one of the most pressing health issues in the United States today. Consequently, analgesic adjuncts, such as multimodal drug regimens and regional anesthetic blocks (like transversus abdominis plane (TAP) block), have been introduced to the perioperative period in hopes of decreasing postoperative opiate use. However, the effect of these interventions on intraoperative opiate use has not been examined. We hypothesized that preoperative TAP block would be associated with decreased intraoperative opiate use during minimally invasive cholecystectomy. METHODS: This was a retrospective review of patients undergoing minimally invasive cholecystectomy between June 2018 and January 2021. Perioperative data, operative times, and medication administration data were collected. Intraoperative opiate use was calculated in total morphine equivalent doses (MED) for each patient and adjusted for operative time. Univariate analysis and multivariate linear regression were performed to determine factors affecting intraoperative opiate requirements. RESULTS: 261 patients were included in this study, of which 62 (23.8%) received preoperative TAP block and 199 (76.2%) did not. Preoperative TAP block was associated with decreased intraoperative opiate use (0.199 vs 0.312, p < 0.001), while there were no statistically significant differences associated with other analgesic adjuncts including preoperative acetaminophen (p = 0.485), celecoxib (p = 0.112), gabapentin (p = 0.165), or intraoperative ketorolac (p = 0.200). On multivariate analysis, preoperative TAP block was independently associated with decreased intraoperative opiate use (< 0.001), while chronic cholecystitis on final pathology was associated with increased intraoperative opiate use (p = 0.002). CONCLUSION: The use of preoperative TAP block was associated with decreased intraoperative opiate use during minimally invasive cholecystectomy and should be considered for routine use. Future research should investigate whether preoperative TAP blocks and a subsequent decrease of intraoperative opiates, also result in a decrease in postoperative opiate use and improvements in postoperative outcomes.
引用
- Zarate Rodriguez J, Edgley C, Lee S, et al. Preoperative transversus abdominis plane block decreases intraoperative opiate consumption during minimally invasive cholecystectomy. Surg Endosc. 2022. PMID: 35864354. doi:10.1007/s00464-022-09445-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。